Whats Happening to Thyroid Patients Taking Eltroxin Brand Levothyroxine in New Zealand?
What’s Happening to Thyroid Patients Taking Eltroxin Brand Levothyroxine in New Zealand? Saturday June 7, 2008 Folks in New Zealand are up in arms, because a reformulation of the drug Eltroxin (a brand name of levothyroxine manufactured by GlaxoSmithKline) appears to be causing problems in thyroid patients. Patients taking Eltroxin (which is government funded in New Zealand) are reporting all sorts of side effects and symptoms since the drug was recently reformulated. According to a company spokesperson, the reformulation was necessary due to changes in the manufacturing operation, moving the production of the Eltroxin from Canada to Germany. While GlaxoSmithKline is saying that levothyroxine in Eltroxin is the same, there are new filler and binders in the reformulated product. The Southland Times has more information. Are you in New Zealand and taking the new Eltroxin? Share your stories here in the comments section
